Company intelligence / Profile preview

Mountain View Pharmaceuticals

Menlo Park, California, United Statesmvpharm.com ↗

Ownership: Private
Employees: ~7
Development stage: Other

Overview

Mountain View Pharmaceuticals specializes in the development of innovative PEGylated biologics to improve therapeutic efficacy and pharmacokinetics. Their most notable contribution was the co-development of pegloticase (KRYSTEXXA™), a PEGylated uricase enzyme approved by the FDA in partnership with Bio‑Technology General/Savient Pharmaceuticals for chronic gout. The company also conducts early-stage research on PEGylated prolactin receptor antagonists as potential cancer therapeutics.

Therapeutic areas: RheumatologyOncology
Modalities: ProteinBiologicPolymer-drug conjugate therapy
Industry: Biotech

Drug pipeline

1 asset

pegylated granulocyte-macrophage colony-stimulating factor

Preclinical

Partnerships

Bio‑Technology General/Savient Pharmaceuticals/BIRD Foundation collaboration on pegloticase/KRYSTEXXA™ development

Beyond the preview

Go deeper on Mountain View Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mountain View Pharmaceuticals.